To view the PDF file, sign up for a MySharenet subscription.

Astral Foods - Audited results for the year ended 30 September 2006

Release Date: 10/11/2006 07:00
Code(s): ARL
Wrap Text

Astral Foods - Audited results for the year ended 30 September 2006 Astral Foods Incorporated in the Republic of South Africa Registration no 1978/003194/06 Share code ARL ISIN: ZAE000029757 Audited results for the year ended 30 September 2006 * Operating profit increase 28% * Headline earnings per share increase 34% * Dividend increase 54% Condensed Income Statement Restated
Audited Audited Year Year ended ended 30 Sept 30 Sept
2006 Change 2005 R"000 % R"000 Revenue 5 183 664 7 4 838 284 Operating profit (note 6) 765 953 28 596 709 Net finance income/(costs) 4 884 (11 323) Profit before income tax 770 837 32 585 386 Income tax expense (254 (169 852) 339)
Profit for the year 516 498 24 415 534 Attributable to: Equity holders of the parent 509 517 24 410 242 company Minority interests 6 981 32 5 292 Profit for the year 516 498 24 415 534 Earnings per share (cents) - basic 1 285 30 989 - diluted 1 268 32 961 Additional Information Headline earnings (R"000) 509 803 28 397 466 Headline earnings per share (cents) - basic 1 286 34 958 - diluted 1 269 36 932 Dividend per share (cents) - declared out of earnings 585 54 380 for the year Ordinary shares - Issued net of treasury 38 949 40 569 shares 578 574 - Weighted-average 39 643 41 482 913 050 - Diluted weighted-average 40 177 42 668 944 767 Net asset value per share 28,28 19 23,83 (rand) Condensed Balance Sheet Assets Non-current assets 1 182 692 977 606 Property, plant and 1 038 328 833 477 equipment Intangible assets 141 725 140 982 Investments and loans 1 394 2 284 Deferred income tax asset 1 245 863 Current assets 989 541 847 710 Inventories 198 228 155 200 Biological assets 214 354 198 474 Trade and other receivables 448 031 428 503 Cash and cash equivalents 128 928 65 533 Total assets 2 172 233 1 825 316 Equity Capital and reserves attributable to equity holders of the parent company 1 101 622 966 603 Issued capital 93 711 253 765 Reserves 1 007 911 712 838 Minority interests in equity 19 332 16 589 Total equity 1 120 954 983 192 Liabilities Non-current liabilities 248 879 209 278 Long-term liabilities 9 600 1 759 Deferred income tax 171 399 146 095 liability Retirement benefit 67 880 61 424 obligations Current liabilities 802 400 632 846 Trade and other liabilities 734 601 571 657 Current income tax 55 787 58 965 liabilities Short-term borrowings 12 012 2 224 Total liabilities 1 051 279 842 124 Total equity and liabilities 2 172 233 1 825 316 Net surplus cash 107 316 61 550 Condensed Cash Flow Statement Cash operating profit 868 896 659 817 Working capital changes 84 384 170 466 Cash generated from operating 953 280 830 283 activities Net finance income/(costs) 4 884 (11 323) Income tax paid (234 434) (196 055) Cash flows from operating 723 730 622 905 activities Net cash used in investing (298 885) (154 863) activities Cash generated for the year 424 845 468 042 Cash used in financing (364 144) (447 270) activities Proceeds from issue of 6 117 8 209 shares Buy-back of shares (190 (140 675) 589) Dividends paid (195 114) (117 180) - to the company"s (190 876) (112 009) shareholders - to minority interests (4 238) (5 171) Increase/(decrease) in 15 442 (197 624) borrowings Net increase in cash and cash 60 701 20 772 equivalents Effects of exchange rate 2 694 (520) changes Cash and cash equivalent 65 533 45 281 balances at beginning of year Cash and cash equivalent 128 928 65 533 balances at end of year Condensed Statement of Changes in Equity Balance beginning of year as 915 371 764 828 previously stated Revised useful life of 62 065 46 642 property, plant and equipment Transfer of translation (785) - reserves Full consolidation of 6 541 5 908 business unit Restated balance beginning of 983 192 817 378 year Profit for the year 516 498 415 534 Movement in currency 974 19 translation difference during the year Dividends declared during the (195 238) (117 273) year Decrease in equity as result (190 589) (140 675) of buy-back of shares Shares issued 6 117 8 209 Balance at end of year 1 120 954 983 192 Segment Information Revenue Animal Nutrition 2 670 6 2 516 - South Africa 2 501 5 2 388 - Other Africa 169 32 128 Poultry - South Africa and 3 623 8 3 356 Swaziland Inter group (1 109) (1 034) 5 184 7 4 838
Operating profit Animal Nutrition 272 27 214 - South Africa 235 21 194 - Other Africa 37 85 20 Poultry - South Africa and 494 29 383 Swaziland 766 28 597
Notes 1. Basis of preparation The condensed consolidated financial information announcement is based on the audited financial statements of the Group for the year ended 30 September 2006 which have been prepared in accordance with International Financial Reporting Standards ("IFRS"), the Listings Requirements of the JSE Limited and the South African Companies Act (1973). The financial statements for the year ended 30 September 2006 are Astral Foods Limited"s first published financial statements stating compliance with IFRS. Refer to the reconciliation of previous SA GAAP to IFRS for the effects of IFRS compliance on previously reported financial statements. The nature of all items reconciling SA GAAP to IFRS has been described in detail in the financial statements for the year ended 30 September 2006. 2. Independent audit by the auditors These condensed consolidated results have been audited by our auditors PricewaterhouseCoopers Inc. who have performed their audit in accordance with the International Standards in Auditing. A copy of their unqualified audit report is available for inspection at the registered office of the company. 3. Transition to IFRS The Group has made the following elections in terms of IFRS 1 (First-time Adoption of International Financial Reporting Standards) as at the transition date (1 October 2004): * Cumulative translation differences of foreign operations at date of transition to IFRS amounting to R8 004 000, were set to zero. * Goodwill resulting from acquisitions prior to the date of transition to IFRS was not restated, and represents the written down value as previously recorded under SA GAAP. Goodwill was tested for impairment at date of transition. * IAS 16 requires the reassessment of assets" useful life and residual values at each balance sheet date. Applying this statement retrospectively to the net book values of property, plant and equipment, has had the effect of the results being restated. * Except as stated above, the accounting policies of the Group are consistent in all other material respects with those applied in the previous financial year. 4. Adjustments of prior period results reported under SA GAAP * Consolidation of a business unit at 100% (previously proportionately consolidated at 82%). * Reclassification of feed sales to contract growers as revenue, previously set off against cost of goods sold. The effect of the adjustment is to increase revenue and cost of goods sold each by R224 996 773. * Application of offset to amounts in respect of contract growers separately disclosed under trade receivables and trade payables where a legal right of offset exists. 5. Reconciliation of previous reported SA GAAP to IFRS Profit Equity
attributable to Total Total for the equity holders of assets Liabili- year the parent ties
30 Sept 30 Sept 30 Sept 30 Sept 1 Oct 2005 2005 2005 2005 2004 R"000 R"000 R"000 R"000 R"000 As previously 1 802 484 887 113 397 768 906 092 754 953 reported IFRS adjustments Property, 86 416 25 136 15 423 60 511 45 957 plant and equipment (note 3) SA GAAP adjustments Full 7 013 472 2 343 - - consolidation of business unit (note 4) Offset of (70 597) (70 597) - - - trade receivables and trade payables (note 4) Restated under 1 825 316 842 124 415 534 966 603 800 910 IFRS The comparative results have accordingly been restated in terms of the International Reporting Standards accounting principles as set out in this report. Restated
Audited Audited Year Year ended ended 30 Sept 30 Sept
2006 2005 R"000 R"000 6. Operating profit The following items have been accounted for in the operating profit: Auditors" remuneration 3 503 2 637 Biological assets - fair value 710 (218) gain/(loss) Amortisation of intangible 2 969 1 046 assets Depreciation on property, plant 85 766 76 693 and equipment Profit on disposal of property, 47 15 287 plant and equipment Foreign exchange (loss)/profit (390) 2 283 7. Reconciliation to headline earnings Earnings for the year 509 517 410 242 Profit on sale of property, (303) (13 875) plant and equipment Loss related to investments 589 1 099 written off and sale of business unit Headline earnings for the year 509 803 397 466 8. Share capital In terms of the share buy-back programme 2 344 247 shares were acquired during the period under review at a total costs of R190 589 000. In terms of the Group"s share incentive scheme, 724 251 shares were issued in respect of share options exercised during the period under review. 9. Capital commitments Capital expenditure approved not 58 557 23 484 contracted Capital expenditure contracted not 65 628 44 814 recognised in financial statements Financial overview Results for the year showed significant improvement with headline earnings per share increasing by 34%. While the performance of the second half of the year did not match the first half due to substantially higher maize prices, they were nevertheless better than last year"s record second half earnings. Revenue increased by 7% from R4,8 billion to R5,2 billion and operating profit by 28% from R597 million to R766 million with both the Animal Nutrition and Poultry divisions reporting satisfactory growth of 27% and 29% respectively. Group operating margin of 14,8% was up on last year"s 12,3%. Interest income of R4,9 million compares with the prior year"s interest paid of R11,3 million. The effective tax rate (inclusive of STC) of 33,0% is well up on last year"s 29,0% following higher STC payments as the group increased its dividend, prior year adjustments and the once off benefit last year following the 1% reduction in the statutory tax rate. The Group is gearing itself for further growth and as a result capital expenditure increased from the prior year"s R178 million to R297 million. Return on net assets improved from 51% to 65%. Net cash inflow from operating activities of R723 million was up 16% from the previous year. Following the share buy-back of R190 million (2005: R145 million), high levels of capital expenditure and increased dividend payments of R195 million (2005: R117 million), the year-end net cash increased from R62 million to R107 million. The dividend cover for the year has been lowered to 2,2 times (2005: 2,5 times). The total dividend for the year of R5,85 per share is 54% up on last year"s R3,80. A final dividend of R3,60 (2005: R2,60) was declared. Return on equity improved to 49% (2005: 46%) and economic value added increased from R252 million to R418 million based on a weighted average cost of capital of 14%. Review of operations Animal Nutrition The final maize crop estimate for the 2006 season is 6,2 million tons, the smallest crop since 1995. The large carry-out stocks in excess of 3,5 million tons from last year was depleted to a tight carry-out stockholding of around 1,6 million tons this year. This situation resulted in prices rising substantially over the past financial year. The maize market is now focusing on the huge jump in international prices, the recent volatility of the ZAR/USD exchange rate, intentions to plant for the new season and local weather conditions. Other key raw materials, soya beans and fish meal, also increased significantly. These market conditions were anticipated. Animal Nutrition reported strong results with revenue of R2,7 billion (2005: R2,5 billion), 6% up on the prior year. Operating profit of R272 million (2005: R214 million) was a pleasing 27% up on the prior year. Operating margins improved from 8,5% to 10,2%. Other factors that contributed to this performance were the maintaining of volumes in a competitive market, tight cost control and a strong performance from the Zambian operation. The division managed to contain operating costs in rand value at the same level as the prior year. The teething problems experienced at the new Port Elizabeth mill during previous years are being overcome. This mill recorded a significant turnaround during the year and further improvements can be expected. A small mill in Ladismith, Southern Cape has been acquired and is expected to make a positive contribution in the new financial year. NuTec SA and National Veterinary Services reported excellent profits for the year but the results of Central Analytical Laboratories disappointed. Increased sales of feed due to the poultry division"s expansion will be realised in the coming financial year. Poultry The benefit of the previous year"s low maize prices continued into the current year. Feed expenditure for the year on average for this division decreased by 2%. Revenue increased by 8% from R3,4 billion to R3,6 billion. With a 6% increase in selling prices, and the reduction in feed costs, combined with improved production efficiencies, operating profit increased by 29% from R383 million to R494 million. Operating margins improved from 11,4% to 13,6%. Sporadic outbreaks of Newcastle disease continued into 2006. Anti-dumping duties against the USA producers were renewed by the Minister of Trade and Industry in October 2006. The benefits of the expansion programme at the Earlybird division will start to flow through from December 2006. To date the Avian Influenza epidemic has not impacted on the South African poultry industry. Strict bio-security measures have been implemented to counter any outbreak of the disease. All poultry operations reported strong results with the exception of National Chicks which reported no growth as a result of the impact of Newcastle disease. Prospects Subsequent to the year-end the Board approved a R202 million capacity expansion and processing efficiency improvement project at the Earlybird division which will be commissioned in the last quarter of the coming financial year. Together with the current expansion project this will result in significant benefits for both the feed mills and the poultry division. Earnings are expected to improve further in 2007. Higher anticipated plantings of maize are expected to result in lower prices. Against the above background, and expected high consumer spending on poultry products we look forward to another good year. Declaration of Ordinary Dividend No. 12 Notice is hereby given that a final dividend (no.12) of 360 cents per ordinary share has been declared in respect of the year ended 30 September 2006. Salient dates 2007 Last date to trade cum-dividend Friday, 5 January Shares commence trading ex-dividend Monday, 8 January Record date Friday, 12 January Payment of dividend Monday, 15 January Share certificates may not be dematerialised or rematerialised between Monday, 8 January 2007 and Friday, 12 January 2007, both days inclusive. On behalf of the board J L van den Berg Chairman N C Wentzel Chief Executive Officer Pretoria 9 November 2006 Registered office Block E, Castle Walk Office Park, Erasmuskloof, Pretoria Postnet 329, Private Bag X10, Elarduspark, 0048 Telephone: (012) 347-5077 Website address: www.astralfoods.com Directors J L van den Berg (Chairman), *N C Wentzel (Chief Executive Officer), *T Pritchard (Financial Director) *M A Kingston, *C E Schutte, J J Geldenhuys, C G van Veyeren, M Macdonald, T C C Mampane (*Executive director) Company Secretary M Eloff Transfer secretaries Computershare Investor Services 2004 (Pty) Limited PO Box 61051 Marshalltown, 2107 Telephone: (011) 370-5000 Sponsor JP Morgan Chase Bank NA, (Johannesburg Branch) 1 Fricker Road, Illovo Johannesburg, 2146 Private Bag X9936 Sandton, 2146 Telephone: (011) 507-0430 Date: 10/11/2006 07:00:27 AM Supplied by www.sharenet.co.za Produced by the JSE SENS Department

Share This Story